| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.7M | +13.0% |
| Cost of Revenue | $7.9M | +7.9% |
| Gross Profit | $14.9M | +15.9% |
| R&D Expense | $8.6M | -11.9% |
| SG&A Expense | $4.5M | -19.4% |
| Operating Income | -$4.7M | +46.8% |
| Pre-tax Income | -$7.0M | +35.1% |
| Income Tax | $12K | — |
| Net Income | -$7.0M | +35.0% |
| EPS (Basic) | -$0.67 | +40.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.8M | -19.0% |
| Inventory | $1.6M | -11.0% |
| Current Assets | $8.1M | -35.1% |
| Total Assets | $19.5M | -21.7% |
| Current Liabilities | $7.8M | +26.0% |
| Total Liabilities | $17.7M | +3.2% |
| Stockholders' Equity | -$18.2M | -48.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | +79.1% |
| Capital Expenditures | $1.4M | +261.8% |
| Investing Cash Flow | -$1.4M | -83.2% |
| Financing Cash Flow | -$1.0M | -107.2% |
| Free Cash Flow | -$2.8M | +60.7% |